ASX Health Care Index (XHJ): Healthcare Stocks Weaken as Resources Drive Market Gains

Aditi Sarkar

22 July 2026 04:20 PM AEST

ASX Health Care Index (XHJ): Healthcare Stocks Weaken as Resources Drive Market Gains

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Highlights

ASX Health Care Index declined around 1.08% during delayed intraday trading on 22 July 2026.
Healthcare shares underperformed while resource sectors led the Australian market.
No confirmed sector-wide catalyst accompanied the decline.
Earnings, regulatory developments and product demand remain key investor focus areas.

The ASX Health Care Index (XHJ) traded lower during delayed intraday trading on 22 July 2026, falling approximately 1.08% to around 42,987.60. The decline came as investors favoured mining, gold and energy companies, leaving healthcare among the weaker-performing sectors. Although the movement attracted market attention, no confirmed sector-wide catalyst was identified behind the decline.

The broader Australian sharemarket reflected strong buying across commodity-linked sectors, while healthcare companies generally traded lower. Several medical technology and healthcare businesses recorded declines during the session as investor interest shifted towards resource-related stocks. Although portfolio rotation, broader market sentiment and routine trading activity may have influenced the sector, no single event has been confirmed as the reason behind the decline.

The ASX Health Care Index tracks Australian-listed companies operating across pharmaceuticals, biotechnology, medical devices, healthcare services and related industries. Sector performance is influenced by regulatory approvals, clinical developments, product demand, commercial execution, earnings performance and broader investor sentiment. Given its mix of established healthcare providers and growth-oriented biotechnology companies, the index can experience varying levels of volatility.

Performance across the sector remained mixed during the session, with individual companies responding to their own commercial and operational developments. Differences in business models, product pipelines and financial performance continued to influence individual share price movements despite the broader decline.

Looking ahead, investors are likely to monitor corporate earnings, regulatory approvals, clinical milestones, product demand and future company announcements. Broader developments across the healthcare industry and the wider economy may also continue shaping sentiment towards the sector.

Like other industries, healthcare companies face several operational and market-related risks. Regulatory uncertainty, clinical development risks, competitive pressures, funding requirements, changing healthcare demand and broader market volatility may all influence future performance. Investors are therefore likely to continue monitoring both company-specific developments and wider industry trends.

What Investors May Watch

Investors may monitor earnings updates, regulatory approvals, clinical progress, product demand and future company announcements.

Risks

Key risks include regulatory uncertainty, clinical development risks, competitive pressures, funding requirements, changing healthcare demand and broader market volatility.

FAQs

Q: What does the ASX Health Care Index represent?

A:The ASX Health Care Index tracks Australian-listed companies operating across pharmaceuticals, biotechnology, medical technology and healthcare services.

Q: Why did the ASX Health Care Index decline?

A:No confirmed sector-wide catalyst was identified. The decline coincided with stronger investor interest in mining and other commodity-related sectors.

Q: What influences the ASX Health Care Index?

A:Regulatory approvals, clinical developments, earnings, product demand and investor sentiment are among the key influences.

Q: What should investors monitor going forward?

A:Investors may watch earnings updates, regulatory developments, clinical milestones, product demand and future company announcements.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.